Search - tctmd.com

Displaying 141 - 160 of 226

Sort: Relevancy | Date

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

Presentation TCT 2015

TCT 50: Peri-strut Low-Intensity Area Assessed by Midterm Follow-up Optical Coherence Tomography May Predict Target Lesion Revascularization After Stent Implantation

Presenter: Stephan Achenbach, Marc D. Feldman, Koji Kuroda

October 13, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Conference News TCT 2015

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

News Conference News TCT 2014

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

September 17, 2014

Presentation TCT 2014

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Miha Cercek

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Advertisement

IN.PACT SFA: Benefits of DCB Persist at 2 Years

TCT 50: Peri-strut Low-Intensity Area Assessed by Midterm Follow-up Optical Coherence Tomography May Predict Target Lesion Revascularization After Stent Implantation

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Very Late Stent Thrombosis Remains an Important Clinical Target

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

Absorb BVS Matches Xience V in Chinese Patients

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content